Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Cellular and Molecular Life Sciences | journal | 4.190 Q1 | 261 | 297 | 912 | 27852 | 6861 | 900 | 6.90 | 93.78 | 39.56 | |
2 | Molecules | journal | 0.720 Q1 | 227 | 757 | 1294 | 30780 | 3570 | 1290 | 2.70 | 40.66 | 38.85 | |
3 | Marine Drugs | journal | 0.983 Q1 | 159 | 171 | 240 | 9262 | 1110 | 239 | 4.46 | 54.16 | 42.64 | |
4 | Frontiers in Pharmacology | journal | 0.166 Q3 | 154 | 88 | 41 | 5841 | 32 | 41 | 0.78 | 66.38 | 32.42 | |
5 | AAPS PharmSciTech | journal | 0.684 Q1 | 116 | 155 | 541 | 4241 | 1074 | 541 | 1.85 | 27.36 | 38.08 | |
6 | Toxins | journal | 0.337 Q3 | 116 | 91 | 168 | 6200 | 187 | 167 | 1.11 | 68.13 | 39.74 | |
7 | Inflammation Research | journal | 0.661 Q2 | 107 | 137 | 429 | 5008 | 833 | 425 | 1.93 | 36.55 | 36.41 | |
8 | Pharmaceutics | journal | 0.274 Q2 | 106 | 49 | 30 | 3202 | 24 | 29 | 0.80 | 65.35 | 40.18 | |
9 | Pharmaceuticals | journal | 0.431 Q2 | 87 | 89 | 208 | 7520 | 256 | 204 | 1.23 | 84.49 | 32.59 | |
10 | Skin Pharmacology and Physiology | journal | 1.285 Q1 | 86 | 44 | 143 | 1686 | 539 | 129 | 3.24 | 38.32 | 38.92 | |
11 | Antibiotics | journal | 0.121 Q4 | 77 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
12 | Inflammopharmacology | journal | 0.849 Q2 | 68 | 36 | 102 | 1754 | 311 | 99 | 2.47 | 48.72 | 29.91 | |
13 | Pharmacology | journal | 0.725 Q2 | 67 | 90 | 285 | 2968 | 587 | 258 | 1.73 | 32.98 | 35.62 | |
14 | Molecular Diversity | journal | 0.864 Q2 | 63 | 98 | 159 | 3755 | 476 | 153 | 2.89 | 38.32 | 28.61 | |
15 | Chemotherapy | journal | 0.694 Q2 | 61 | 51 | 206 | 1741 | 394 | 201 | 1.70 | 34.14 | 40.65 | |
16 | Scientia Pharmaceutica | journal | 0.381 Q2 | 54 | 64 | 161 | 1844 | 215 | 156 | 1.25 | 28.81 | 27.54 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®